United States, California, Los Angeles - 08/01/2019 (PRDistribution.com)
Leonhardt's Launchpads has 15 products in clinical trials and 15 more in pre-clinical studies for bioelectric and biologics based organ regeneration and recovery and over 400 patent claims issued, pending, licensed or optioned.
Leonhardt's Launchpads by Cal-X Stars Business Accelerator, Inc. of Los Angeles announced today expansion into the life science incubator research lab facilities (Martin Laboratory Incubator) at LA BioMed with access privileges to BioLabs LA which is across the street.
Leonhardt's Launchpads founded in California in 2008 is an innovation accelerator focused primarily on bioelectric and biologics-based organ/tissue regeneration and recovery.
Over 500 patients have been enrolled in bioelectric and biologics based organ regeneration and recovery clinical studies thus far sponsored by Leonhardt's Launchpads founded startups.
Leonhardt's Launchpads innovations and startups are categorized in these focused groups https://leonhardtventures.com/development-pipeline/:
1. Heart & Cardiovascular.
3. Cosmetic and Reproductive Health.
4. Major Organ Regeneration.
"We are amazed at the resources available at the LA BioMed and BioLabs LA facilities and the adjacent Harbor UCLA Medical Center for translational research. Our team looks forward to integrating with LA BioMed researchers in multiple bioelectric and biologics focused applications for organ regeneration and recovery," states Howard J. Leonhardt, Executive Chairman & CEO, Leonhardt's Launchpads.
Leonhardt's Launchpads has active collaborations with researchers at UCLA, USC, CalTech, Pepperdine, Pacific Neurosciences Institute and Hoag Hospital in the Los Angeles area and is a member of ScaleLA and SoCal Bio two local life science industry resources.
Dr. Robert Gelfand, a long standing LA BioMed researcher, and graduate of MIT, CalTech and UCSB biological sciences will serve as the Los Angeles Research Lab Manager for Leonhardt's Launchpads working at the newly dedicated laboratory location at the Martin Building Incubator at LA BioMed with limited access privileges to BioLabs LA across the street.
"I strongly believe in the convergence of precise bioelectric signaling for controlling regenerative protein expressions on demand and re-fillable micro pump slow infusion of stem cell-based mixed biological compositions for organ + tissue regeneration and recovery. I am really excited to be joining this team that has pioneered so many great innovations over so many years at their new Los Angeles based research laboratory at LA BioMed" stated Dr. Robert Gelfand, Los Angeles Research Lab Manager for Leonhardt's Launchpads.
Leonhardt's Launchpads has strong working collaborations with Mettler Electronics and DeviceLab in Orange County, California, QIG Greatbatch in Santa Clarita, Fluid Synchrony in Pasadena as well as REV1 Engineering in Murrieta, California to advance product candidates in research and development.
"We are excited to welcome back a team that pioneered leading therapies with LA BioMed in the 1990s to now join our Martin incubator where they will focus on bioelectric and biologics based organ regeneration," stated Keith Hoffman, Vice President of Business Development and Technology Transfer at LA BioMed.
"It is great to welcome Leonhardt's Launchpads to the BioLabs LA affiliate membership program granting their R&D team leaders limited access to events and select facilities at our location directly across the street from the Martin Research Laboratory Incubator at LA BioMed where they will be based," stated Gary Olsem, Site Director BioLabs Los Angeles.
The Leonhardt's Launchpads innovation and startup accelerator business model is to accelerate each organ specific innovation through first in human studies and then seek a strategic partner/buyer to advance the development the rest of the way to commercialization. Approximately five organ specific innovations and corresponding startups are set to be ripe for a strategic partnership each year for the next 6 years.
About Leonhardt's Launchpads:
Formed in 2008 in Santa Rosa, California with its headquarters moved to the Los Angeles area in 2012 and incorporated in 2013 as Leonhardt's Launchpads by Cal-X Stars Business Accelerator, Inc. Leonhardt's Launchpads is the innovation and startup accelerator arm of Howard Leonhardt's Leonhardt Ventures founded in 1982. Leonhardt's Launchpads focuses on bioelectric and biologics based organ regeneration innovations. 30 startups are in the 2019 portfolio class. Over 140 experienced mentors and advisors serve the accelerator startups.
About Leonhardt Ventures:
Founded in 1982 as HJ Leonhardt & Co and formed into a LLC in 2005 in California (Leonhardt Vineyards LLC DBA Leonhardt Ventures) is the commercialization arm of inventor Howard J. Leonhardt with a focus on organ regeneration and recovery, food & beverage and social good impact startup creation and development. The Leonhardt team pioneered cardiovascular balloon catheters in the 1980's, stent grafts, biological pacemakers and percutaneous heart valves in the 1990s and since 1999 has focused on bioelectric and biologics based organ regeneration. In 2001 Leonhardt led a team that competed the historic first ever muscle stem cell based non-surgical repair of a human heart. Over 500,000 patients have been treated with Leonhardt inventions to date - https://patents.justia.com/inventor/howard-j-leonhardt.
About LA BioMed & Martin Research Laboratory Incubator:
LA BioMed is an incubator of innovation with a global reach and a 67-year reputation of improving and saving lives. Driven by the positive social impacts of breakthrough therapies, the Southern California-based incubator and research institute – with over 100 principal investigators (PhDs, MDs and MD/PhDs) working on over 600 research studies, including therapies for multiple orphan diseases – is an essential element to one of the nation's top-ten biotech clusters. Find out more at https://labiomed.org.
About BioLabs LA at LA BioMed:
BioLabs is a membership-based network of shared lab facilities in the nation’s key biotech innovation clusters, designed exclusively for high-potential, early-stage life science companies. It offers co-working environments that pair premium, fully equipped and supported lab and office space with unparalleled access to capital and industry partners. This fertile, supportive ecosystem allows nascent companies to shift their focus from startup operations to innovation so they can reach their scientific potential quickly and achieve business success. Companies can start with a single bench, and scale up as they grow -See https://www.biolabs.io/los-angeles/biolabs-los-angeles-now-open
BioLabs LA BioMed is:
· Located at a 78,000-square foot, $65 million research building at LA BioMed next to the Harbor-UCLA Medical Center in Torrance;
· An 18,000-square foot facility that offers users access to state-of-the-art lab and office facilities, more than $1 million in shared equipment, and world-class programming and events from world-class programming and events from LA BioMed’s distinguished roster of more than 400 researchers, several of whom have launched their own startups; and
· Premium co-working space that is designed to scale to a company’s growth, whether a single lab bench or a suite of offices
Leonhardt's Launchpads by Cal-X Stars Business Accelerator, Inc., 12655 W Jefferson Blvd, Los Angeles, CA 90066
Los Angeles Research Lab 1124 W Carson St, Torrance, CA 90502
Leonhardt's Launchpads Utah, Inc. 370 S, 300 E, Salt Lake City, UT 84111
Research Lab @ 2500 S State St. #224, Salt Lake City, UT 84115
Google Voicemail All Locations: (424) 291-2133, Master Web Site www.leonhardtventures.com
Warnings and Disclaimers: Patents pending may not be issued. Patents issued, licensed or optioned may not be maintained. Products may be found to infringing on other patents. *Products are early stage in development and are not yet proven safe or effective.* Company lacks sufficient resources to bring these products fully to commercialization. As an investment these early stage startups have to be regarded in the highest risk category for total loss. Forward looking statements are subject to change without notice. Any timelines, implied or quoted, are highly subject to change even by years. Company is understaffed and underfunded by typical standards to complete any of its product developments. The company is highly dependent on a few key individuals and suppliers to move forward its developments at this time. With a small staff information across over 50 plus maintained web sites maybe out of date at any time.
Additional Regulatory Warning Note - Our primary bench top bioelectric stimulator OEM sourced from Mettler Electronics of Anaheim, California founded in 1957 https://www.mettlerelectronics.com/history/ has FDA 510K - K113017 - market clearance ONLY for improving blood circulation, mild pain relief, relief of arthritis related stiffness and accelerated muscle injury recovery. Any other indications of use require clinical data to be gathered to support additional new regulatory filings to gain proper regulatory clearances for additional labelling indications of use. None of our startups products are for sale anywhere worldwide. *Products are only available for investigational use ONLY where proper regulatory permissions have been granted including government and institutional review board (IRB) approvals where necessary and in all cases appropriate patient consent process has been followed properly communicating all associated risks clearly.* We make no claims that our products are safe or effective especially for any indications of use outside of the 510K cleared indications mentioned above.